Liver fibrosis: Noninvasive diagnosis with double contrast material-enhanced MR imaging
Liver fibrosis: Noninvasive diagnosis with double contrast material-enhanced MR imaging
复制标题
DOI:
10.1148/radiol.2392050505
复制
发表时间:
2006-05-01
期刊:
影响因子:
19.7
通讯作者:
Sirlin, CB
中科院分区:
文献类型:
--
作者:
Aguirre, DA;Behling, CA;Sirlin, CB
Purpose: To retrospectively evaluate the accuracy of double contrast material-enhanced (hereafter double-enhanced) magnetic resonance (MR) imaging depiction of hepatic fibrosis, with histopathologic analysis findings as the reference standard.Materials and Methods: The institutional review board approved this HIPAA-compliant study and waived the requirement for informed consent. One hundred one patients (58 men, 43 women; mean age +/- standard deviation, 52 years +/- 10) who underwent double- enhanced MR imaging with superparamagnetic iron oxide (SPIO)-enhanced and double- enhanced spoiled gradient-echo (SPGR) sequences between 2001 and 2004 and had a reliable reference standard for the diagnosis of liver fibrosis were included. Two blinded MR radiologists retrospectively scored qualitative (reticulation, nodularity, and total scores) and quantitative (contrast-to- noise ratio between hyperintense and hypointense liver regions, coefficient of variation, and noise-corrected coefficient of variation) liver texture features on MR images in consensus. The image scores for patients with advanced (METAVIR fibrosis score >= 3) versus those for patients with mild ( METAVIR score